BMRN icon

BioMarin Pharmaceuticals

393 hedge funds and large institutions have $16.8B invested in BioMarin Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 149 increasing their positions, 139 reducing their positions, and 51 closing their positions.

Holders
393
Holders Change
+2
Holders Change %
+0.51%
% of All Funds
10.98%
Holding in Top 10
14
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-12.5%
% of All Funds
0.39%
New
55
Increased
149
Reduced
139
Closed
51
Calls
$211M
Puts
$228M
Net Calls
-$16.3M
Net Calls Change
-$51.8M
Name Market Value Shares Shares
Change
Shares
Change %
VanEck Associates
76
VanEck Associates
New York
$26.5M 251,304 -38,203 -13%
Balyasny Asset Management
77
Balyasny Asset Management
Illinois
$26.2M 248,629 -289,129 -54%
Neuberger Berman Group
78
Neuberger Berman Group
New York
$25.4M 240,855 +577 +0.2%
PAMU
79
Pictet Asset Management (UK)
United Kingdom
$24.9M 236,194 -92,903 -28%
Allianz Asset Management
80
Allianz Asset Management
Germany
$24.8M 235,580 +8,395 +4%
MTB
81
Mizuho Trust & Banking
Japan
$24.5M 232,675 +8,547 +4%
TIP
82
Torray Investment Partners
Maryland
$24M 227,845 -2,350 -1%
CCI
83
Columbus Circle Investors
$23.8M 226,384 +10,384 +5%
Marshall Wace
84
Marshall Wace
United Kingdom
$23.8M 226,172 +62,203 +38%
AIMCA
85
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$23.8M 226,000
CS
86
Candriam SCA
Luxembourg
$23.6M 224,162 +10,411 +5%
AQR Capital Management
87
AQR Capital Management
Connecticut
$23M 218,604 -92,080 -30%
State Board of Administration of Florida Retirement System
88
State Board of Administration of Florida Retirement System
Florida
$22.5M 213,397 +2,594 +1%
GC
89
Guggenheim Capital
Illinois
$22.5M 213,233 +7,598 +4%
Lord, Abbett & Co
90
Lord, Abbett & Co
New Jersey
$21.8M 207,014 -177,622 -46%
UBS Group
91
UBS Group
Switzerland
$21.7M 205,765 -29,515 -13%
BJ
92
BlackRock Japan
Japan
$20.9M 197,981 +1,521 +0.8%
Charles Schwab
93
Charles Schwab
California
$20.4M 193,861 -108,777 -36%
O
94
OrbiMed
New York
$19.8M 188,000
TCM
95
Tang Capital Management
California
$19.2M 182,300
ProShare Advisors
96
ProShare Advisors
Maryland
$19.1M 181,521 +44,670 +33%
APG Asset Management
97
APG Asset Management
Netherlands
$18.9M 179,017 -11,995 -6%
SM
98
Sabby Management
Florida
$18.3M 174,073 +174,073 New
William Blair & Company
99
William Blair & Company
Illinois
$17.9M 169,759 -1,071,548 -86%
RhumbLine Advisers
100
RhumbLine Advisers
Massachusetts
$16.5M 156,696 +5,211 +3%